Episurf Medical Management
Management criteria checks 4/4
Episurf Medical's CEO is Pal Ryfors, appointed in Jun 2017, has a tenure of 6.83 years. total yearly compensation is SEK4.50M, comprised of 84.4% salary and 15.6% bonuses, including company stock and options. directly owns 1.12% of the company’s shares, worth €92.05K. The average tenure of the management team and the board of directors is 6.8 years and 7.9 years respectively.
Key information
Pal Ryfors
Chief executive officer
kr4.5m
Total compensation
| CEO salary percentage | 84.4% |
| CEO tenure | 6.8yrs |
| CEO ownership | 1.1% |
| Management average tenure | 6.8yrs |
| Board average tenure | 7.9yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -kr92m |
| Dec 31 2023 | kr5m | kr4m | -kr95m |
| Sep 30 2023 | n/a | n/a | -kr97m |
| Jun 30 2023 | n/a | n/a | -kr94m |
| Mar 31 2023 | n/a | n/a | -kr84m |
| Dec 31 2022 | kr5m | kr4m | -kr77m |
| Sep 30 2022 | n/a | n/a | -kr72m |
| Jun 30 2022 | n/a | n/a | -kr71m |
| Mar 31 2022 | n/a | n/a | -kr69m |
| Dec 31 2021 | kr4m | kr3m | -kr69m |
| Sep 30 2021 | n/a | n/a | -kr67m |
| Jun 30 2021 | n/a | n/a | -kr66m |
| Mar 31 2021 | n/a | n/a | -kr63m |
| Dec 31 2020 | kr4m | kr3m | -kr64m |
| Sep 30 2020 | n/a | n/a | -kr66m |
| Jun 30 2020 | n/a | n/a | -kr69m |
| Mar 31 2020 | n/a | n/a | -kr73m |
| Dec 31 2019 | kr2m | kr2m | -kr70m |
| Sep 30 2019 | n/a | n/a | -kr66m |
| Jun 30 2019 | n/a | n/a | -kr62m |
| Mar 31 2019 | n/a | n/a | -kr59m |
| Dec 31 2018 | kr2m | kr2m | -kr58m |
| Sep 30 2018 | n/a | n/a | -kr58m |
| Jun 30 2018 | n/a | n/a | -kr59m |
| Mar 31 2018 | n/a | n/a | -kr55m |
| Dec 31 2017 | kr2m | kr1m | -kr61m |
Compensation vs Market: Pal's total compensation ($USD411.45K) is about average for companies of similar size in the German market ($USD401.52K).
Compensation vs Earnings: Pal's compensation has been consistent with company performance over the past year.
CEO
Pal Ryfors (40 yo)
6.8yrs
Tenure
kr4,500,000
Compensation
Mr. Pal Ryfors is Independent Director of Vivesto AB since May 2022. He serves as Chief Executive Officer of Episurf Medical AB (publ) since June 2, 2017 and served as its Acting Sales Director since 2021....
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 6.8yrs | kr4.50m | 1.12% SEK 92.1k | |
| Chief Financial Officer | 6.8yrs | no data | 0.042% SEK 3.4k | |
| Chief Operating Officer | 4.8yrs | no data | 0.039% SEK 3.2k | |
| Marketing Director | 7.3yrs | no data | 0.0099% SEK 813.5 | |
| President of Episurf Medical Inc | 2.7yrs | no data | 0.025% SEK 2.1k |
6.8yrs
Average Tenure
40yo
Average Age
Experienced Management: 16E's management team is seasoned and experienced (6.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Chairman of the Board | 2.9yrs | kr200.00k | 0.14% SEK 11.7k | |
| Independent Director | 2.9yrs | kr200.00k | 0.090% SEK 7.4k | |
| Independent Director | 7.3yrs | kr200.00k | 0.11% SEK 9.2k | |
| Member of Clinical Advisory Board & Director | 15.3yrs | kr800.00k | 0.22% SEK 17.9k | |
| Member of Clinical Advisory Board | 8.4yrs | no data | no data | |
| Member of Clinical Advisory Board | 8.4yrs | no data | no data | |
| Member of Clinical Advisory Board | 8.4yrs | no data | no data | |
| Member of Clinical Advisory Board | 8.4yrs | no data | no data | |
| Independent Director | 7.9yrs | kr200.00k | 0.11% SEK 9.2k | |
| Member of Clinical Advisory Board | 7.2yrs | no data | no data | |
| Member of Clinical Advisory Board | 5yrs | no data | no data | |
| Member of Clinical Advisory Board | no data | no data | no data |
7.9yrs
Average Tenure
66yo
Average Age
Experienced Board: 16E's board of directors are considered experienced (7.9 years average tenure).